Publication: Cross-species chemogenomic profiling reveals evolutionarily conserved drug mode of action
No Thumbnail Available
Open/View Files
Date
2010
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Wiley Open Access
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Kapitzky, Laura, Pedro Beltrao, Theresa J Berens, Nadine Gassner, Chunshui Zhou, Arthur Wüster, Julie Wu, et al. 2010. “Cross‐species Chemogenomic Profiling Reveals Evolutionarily Conserved Drug Mode of Action.” Molecular Systems Biology 6 (1): 451. https://doi.org/10.1038/msb.2010.107.
Research Data
Abstract
We present a cross-species chemogenomic screening platform using libraries of haploid deletion mutants from two yeast species, Saccharomyces cerevisiae and Schizosaccharomyces pombe. We screened a set of compounds of known and unknown mode of action (MoA) and derived quantitative drug scores (or D-scores), identifying mutants that are either sensitive or resistant to particular compounds. We found that compound-functional module relationships are more conserved than individual compound-gene interactions between these two species. Furthermore, we observed that combining data from both species allows for more accurate prediction of MoA. Finally, using this platform, we identified a novel small molecule that acts as a DNA damaging agent and demonstrate that its MoA is conserved in human cells. Molecular Systems Biology 6: 451; published online 21 December 2010; doi:10.1038/msb.2010.107
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service